Stay updated on Sensitivity Resistance Mediators in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sensitivity Resistance Mediators in NSCLC Clinical Trial page.

Latest updates to the Sensitivity Resistance Mediators in NSCLC Clinical Trial page
- Check4 days agoChange Detected- Revision: v3.3.4 updated in the page footer; previously shown as v3.3.3.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded New York as a location under the Locations section, expanding recruitment sites. Removed the separate 'New York Locations' entry and the HHS Vulnerability Disclosure in the footer as part of the v3.3.3 revision.SummaryDifference0.2%

- Check54 days agoChange DetectedA minor revision from v3.2.0 to v3.3.2 appears to be a site version or UI update without changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe funding-status notice about government operating status has been removed; the page's core study details remain unchanged.SummaryDifference0.4%

- Check76 days agoChange DetectedNo significant changes were detected between the two screenshots. The page continues to present the study details for NCT02350764 on ClinicalTrials.gov.SummaryDifference0.4%

- Check104 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference4%

Stay in the know with updates to Sensitivity Resistance Mediators in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sensitivity Resistance Mediators in NSCLC Clinical Trial page.